| |
All patient
|
In-patient
|
Out-patient (n = 59)
|
P value
|
|---|
|
(n = 124)
|
(n = 65)
|
|---|
|
Demographics
|
Male (%)
|
83 (66.9)
|
45 (69.2)
|
38 (64.4)
|
0.703
|
|
Age (month) (median; IQR)
|
12.65 (5.7–24.3)
|
6.07 (3.1–11.7)
|
25.34 (15.5–38.2)
|
< 0.001
|
|
Clinical diagnosis
|
Bronchiolitis (%)
|
73 (58.9)
|
37 (56.9)
|
36 (61)
|
0.716
|
|
Pneumonia (%)
|
23 (18.5)
|
23 (35.4)
|
0
|
< 0.001
|
|
Clinical symptoms
|
Fever (%)
|
38 (30.6)
|
29 (44.6)
|
9 (15.3)
|
< 0.001
|
|
Runny nose (%)
|
104 (83.9)
|
55 (84.6)
|
49 (83.1)
|
1
|
|
Cough (%)
|
123 (99.2)
|
64 (98.5)
|
59 (100)
|
1
|
|
Co-infectiona
|
Rhinovirus (%)
|
85 (68.5)
|
63(96.9)
|
22 (37.3)
|
< 0.001
|
|
Respiratory syncytial virus (%)
|
34 (27.4)
|
27 (41.5)
|
7 (11.9)
|
< 0.001
|
|
Adenovirus (%)
|
17 (13.7)
|
5 (7.7)
|
12 (20.3)
|
0.065
|
|
Parainfluenza (%)
|
11 (8.9)
|
6 (9.2)
|
5 (8.5)
|
1
|
|
Human metapeumovirus (%)
|
11 (8.9)
|
3 (4.6)
|
8 (13.6)
|
0.114
|
|
Human bocavirus (%)
|
8 (6.5)
|
6 (9.2)
|
2 (3.4)
|
0.278
|
|
Human coronavirus [HCoV] (%)
|
5 (4)
|
3 (4.6)
|
2 (3.4)
|
1
|
|
Influenza virus (%)
|
3 (2.4)
|
0
|
3 (5.1)
|
0.105
|
|
Parechovirus [PEV] (%)
|
1 (0.8)
|
1 (1.5)
|
0
|
1
|
|
Outcome
|
Death (%)
|
0
|
0
|
0
|
NA
|
- Note: aindicates confirmed by specific (RT)PCR; NA not applicable, IQR interquartile range
